Newomics
Berkeley
About Newomics
Newomics is an early stage biotechnology company that commercializes innovative and integrative platforms and solutions for personalized healthcare. Its proprietary technology is based on silicon-microfluidic-chip for liquid chromatography-mass spectrometry (LC-MS) and offers unprecedented robustness, sensitivity, specificity, and throughput for analyzing molecules from minute amounts of biospecimens such as blood and urine.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $15.7M
- Funding stage: Early Stage Venture
- Last round: Series B (Dec 2020)
- Website: newomics.com
- Phone: (510) 833-2811
Industries & Categories
Biotechnology, Health Care, Wellness
Social Profiles
Canonical: https://fsome.com/organization/newomics-50525 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.